Natalizumab modulates the humoral response against HERV-Wenv73–88 in a follow-up study of Multiple Sclerosis patients

2015 ◽  
Vol 357 (1-2) ◽  
pp. 106-108 ◽  
Author(s):  
Giannina Arru ◽  
Elisa Caggiu ◽  
Stefania Leoni ◽  
Giuseppe Mameli ◽  
Maura Pugliatti ◽  
...  
2014 ◽  
Vol 85 (10) ◽  
pp. 1109-1115 ◽  
Author(s):  
Cecilie Jacobsen ◽  
Jesper Hagemeier ◽  
Kjell-Morten Myhr ◽  
Harald Nyland ◽  
Kirsten Lode ◽  
...  

2007 ◽  
Vol 13 (8) ◽  
pp. 1068-1070 ◽  
Author(s):  
L. Roccatagliata ◽  
MA Rocca ◽  
P. Valsasina ◽  
L. Bonzano ◽  
MP Sormani ◽  
...  

Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment. Multiple Sclerosis 2007; 13 : 1068—1070. http://msj.sagepub.com


2006 ◽  
Vol 245 (1-2) ◽  
pp. 77-85 ◽  
Author(s):  
Agnete Jønsson ◽  
Jente Andresen ◽  
Lars Storr ◽  
Thomas Tscherning ◽  
Per Soelberg Sørensen ◽  
...  

2010 ◽  
Vol 81 (12) ◽  
pp. 1345-1350 ◽  
Author(s):  
L. Rinaldi ◽  
F. Rinaldi ◽  
P. Perini ◽  
M. Calabrese ◽  
D. Seppi ◽  
...  

2000 ◽  
Vol 6 (6) ◽  
pp. 373-377 ◽  
Author(s):  
E. Fisher ◽  
R.A. Rudick ◽  
G. Cutter ◽  
M. Baier ◽  
D. Miller ◽  
...  

2015 ◽  
Vol 359 (1-2) ◽  
pp. 323-327 ◽  
Author(s):  
Fumihito Yoshii ◽  
Shigeharu Takagi ◽  
Eiichiro Nagata ◽  
Yasuhiro Hasegawa ◽  
Naoya Kunika ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (10) ◽  
pp. e111115 ◽  
Author(s):  
Nele Claes ◽  
Tessa Dhaeze ◽  
Judith Fraussen ◽  
Bieke Broux ◽  
Bart Van Wijmeersch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document